Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Mehta

Showing results (51-60 of 247) with videos related to

Pageof 25
Sort By:
Cardiovascular Research|October 28, 1999
Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?J L Mehta, D Y Li
Journal of Cardiovascular Pharmacology and Therapeutics|January 11, 2001
Glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes: conquests and new challengesK M Smith, J L Mehta
Cardiovascular Clinics|January 1, 1987
Anticoagulation in coronary heart disease: heparin and warfarin trialsL M Lopez, J L Mehta
Comprehensive Therapy|March 1, 1986
Hypertension in the elderly: pathophysiology and therapeutic implicationsJ L Mehta, L M Lopez
Indian Heart Journal|January 5, 2002
Interactions between the renin-angiotensin system and dyslipidemia: relevance in atherogenesis and therapy of coronary heart diseaseB K Singh, J L Mehta
Thrombosis Research|April 1, 1990
Leukotriene-receptor antagonist FPL-55712 and t-PA-induced thrombolysis in canine coronary thrombosisJ L Mehta, W W Nichols
Circulation|April 1, 1996
Calcium blockers and risk of myocardial infarction and coronary heart disease mortalityJ L Mehta, V B Subramanian
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoformsL Y Chen, J L Mehta
Journal of the American College of Cardiology|October 13, 1998
Lipoprotein (a): an important risk factor in coronary artery diseaseE A Enas, J L Mehta
Biochemical and Biophysical Research Communications|August 15, 1998
Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cellsJ L Mehta, D Y Li
Pageof 25

Showing results (51-60 of 247) with videos related to

Sort By:
Pageof 25
Cardiovascular Research|October 28, 1999
Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?J L Mehta, D Y Li
Journal of Cardiovascular Pharmacology and Therapeutics|January 11, 2001
Glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes: conquests and new challengesK M Smith, J L Mehta
Cardiovascular Clinics|January 1, 1987
Anticoagulation in coronary heart disease: heparin and warfarin trialsL M Lopez, J L Mehta
Comprehensive Therapy|March 1, 1986
Hypertension in the elderly: pathophysiology and therapeutic implicationsJ L Mehta, L M Lopez
Indian Heart Journal|January 5, 2002
Interactions between the renin-angiotensin system and dyslipidemia: relevance in atherogenesis and therapy of coronary heart diseaseB K Singh, J L Mehta
Thrombosis Research|April 1, 1990
Leukotriene-receptor antagonist FPL-55712 and t-PA-induced thrombolysis in canine coronary thrombosisJ L Mehta, W W Nichols
Circulation|April 1, 1996
Calcium blockers and risk of myocardial infarction and coronary heart disease mortalityJ L Mehta, V B Subramanian
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoformsL Y Chen, J L Mehta
Journal of the American College of Cardiology|October 13, 1998
Lipoprotein (a): an important risk factor in coronary artery diseaseE A Enas, J L Mehta
Biochemical and Biophysical Research Communications|August 15, 1998
Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cellsJ L Mehta, D Y Li
Pageof 25